Dr. Reinhard Laubenbacher, director of the Center for Quantitative Medicine at the UConn School of Medicine and The Jackson Laboratory for Genomic Medicine, has been named an inaugural Fellow of the Society for Mathematical Biology. The Society promotes the development and dissemination of research and education at the interface between the mathematical and biological sciences. The Society serves a diverse community of researchers and educators in academia, industry, and government agencies throughout the world. Dr. Laubenbacher was honored at the Society’s annual meeting in Salt Lake City last month.
Society for Mathematical Biology announces inaugural Fellows of the Society
Dr. Thomas Agresta, director of clinical informatics at the Center for Quantitative Medicine at UConn Health, was asked about his work with the Health IT Advisory Council and the upcoming roundtables.
A series of health information technology community stakeholder roundtables is taking place next week at UConn Health and five other locations throughout the state. Allan Hackney, Connecticut’s health information technology (HIT) officer, will lead the discussions and review the findings of a report prepared for the Health IT Advisory Council.
The UConn Health roundtable is scheduled for Thursday, July 20, from 8 to 9:30 a.m. in the Cell and Genome Sciences Building.
Stakeholder groups include physician, nursing, patient advocacy, consumer-oriented, business, academic health center, health care delivery network, insurer, government agency, business and others. Attendees are asked to register in advance, as space is limited.
Read the Full Article
Brianna Kozemzak of Saint Mary’s College, Notre Dame, IN receives The National Science Foundation Graduate Research Fellowship Program. The NSF Graduate Research Fellowship Program (GRFP) helps ensure the vitality of the human resource base of science and engineering in the United States and reinforces its diversity. The program recognizes and supports outstanding graduate students in NSF-supported science, technology, engineering, and mathematics disciplines who are pursuing research-based master’s and doctoral degrees at accredited United States institutions. Fellows benefit from a three-year annual stipend of $34,000 along with a $12,000 cost of education allowance for tuition and fees (paid to the institution), opportunities for international research and professional development, and the freedom to conduct their own research at any accredited U.S. institution of graduate education they choose.
For more information, visit http://www.nsfgrfp.org.
Paola Vera-Licona, Ph.D., faculty at Center for Quantitative Medicine, has been accepted to participate in the Interstellar Initiative mentoring workshop at the New York Academy of Sciences from March 17-19, 2017. The Interstellar Initiative — presented jointly by the Japan Agency for Medical Research and Development and the New York Academy of Sciences — will recognize the world’s most promising Early Career Investigators in the fields of cancer, regenerative medicine, and neuroscience. Individuals accepted into the Interstellar Initiative will participate in a three-day conference at the New York Academy of Sciences, where they will be grouped within teams of three and asked to propose a solution to a major research question, guided by mentors who are at the peak of their respective disciplines.”
Anna Konstorum, a postdoctoral fellow of Dr. Reinhard Laubenbacher’s research group at Center for Quantitative Medicine, has been awarded a F32 Postdoctoral Fellowship by the National Cancer Institute (NCI) of the NIH.
The project titled “Multiscale modeling of synergistic T cell activation for cancer immunotherapy.”
The sponsor is Dr. Reinhard Laubenbacher of Center of Quantitative Medicine, co-sponsor is Dr. Anthony Vella of the Department of Immunology, and collaborator is Dr. Adam Adler of the Department of Immunology.
Dr. Anna Konstorum will develop both intracellular and multiscale mathematical and computational models of combined agonist stimulation of T cell costimulatory receptors OX40 (CD137) and 4-1BB (CD134). The models will be used to decipher the critical mechanisms and scales underlying the experimentally observed synergistic behavior of these two agonists on CD8+ T cell activation, and thus will aide in the development of a quantitative platform from which to examine multiscale drug synergy for application to cancer immunotherapy.
Dr. Paola Vera-Licona, assistant professor at UConn Health in the Department of Cell Biology and Center for Quantitative Medicine has received a joint appointment as assistant professor in the Department of Pediatrics, University of Connecticut School of Medicine.